Pharmacology · Endocrine Pharmacology

A patient with type 2 diabetes on metformin is started on a sulfonylurea. He presents 3 hours after a meal with sweating, tremors and a blood glucose of 42 mg/dL. Which sulfonylurea is MOST likely to cause this prolonged hypoglycaemia?

  • A Glipizide
  • B Glibenclamide (Glyburide)
  • C Tolbutamide
  • D Gliclazide
Correct answer: B. Glibenclamide (Glyburide)

Explanation

Glibenclamide (glyburide) is a second-generation sulfonylurea with the longest half-life (~10 hours) among commonly used agents, and its active metabolites further prolong hypoglycaemia. It strongly closes pancreatic beta-cell KATP channels independent of glucose concentration. Tolbutamide has the shortest half-life (~4-6 hours) and is the safest in elderly patients. Glipizide and gliclazide have intermediate durations and are safer in renal impairment.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Endocrine Pharmacology MCQs

See all Endocrine Pharmacology MCQs →